TB Drug Trial Course for Selected Patients
04 Jan 2019
As part of a trial phase III, few tuberculosis patients will be given free doses of the drug, Delaminid. Patients subjected to this trial are having multidrug resistance and extensive drug resistance tuberculosis and only patients from Mumbai city are eligible for this. The drugs are given as part of phase III trials and will be received by end of the month. It’s a six months course in which the selected patients will be given two Delaminid tablets of 50 mg each, twice daily along with other tuberculosis drugs. 1.5 lakhs per patient is the amount government have to spend for this course.